[1]
2017. Rivaroxaban and early periprostethic joint infection: our experience. Acta Biomedica Atenei Parmensis. 88, 4 -S (Oct. 2017), 38–42. DOI:https://doi.org/10.23750/abm.v88i4 -S.6792.